Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
JAMA Oncology
|
November 14, 2024
Concerns Regarding Sample Size and Credibility of Progression-Free Survival Results-Reply
Song Dong, Hong-Hong Yan, Yi-Long Wu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Reply to A. Tateishi et al
Yi-Long Wu, Wen-Zhao Zhong, Hong-Hong Yan
The Lancet. Respiratory Medicine
|
November 9, 2017
BRAIN study: it is hard to draw a conclusion - Authors' reply
Jin-Ji Yang, Hong-Hong Yan, Yi-Long Wu
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 18, 2010
[Survey on the development regarding institution and professional contingence of injury prevention and strategy in China]
Hong-hong Yan, Xiao-mei Dong, Gui-bo Chi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2014
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: a meta-analysis of randomized controlled clinical trials
Ning Zhao, Xu-Chao Zhang, Hong-Hong Yan, et al.
International Journal of Clinical Oncology
|
October 7, 2019
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
Zhen Wang, Jin-Ji Yang, Hai-Yan Tu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2014
MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation
Ling Huang, She-Juan An, Zhi-Hong Chen, et al.
BMC Cancer
|
November 8, 2019
Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study
Jia-Tao Zhang, Si-Yang Liu, Hong-Hong Yan, et al.
The International Journal of Biological Markers
|
July 23, 2013
Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
Zhu Zeng, Hua-Jun Chen, Hong-Hong Yan, et al.
Nuclear Medicine Communications
|
September 22, 2011
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
Jin-Ji Yang, Shu-Xia Wang, Wen-Zhao Zhong, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
JAMA Oncology
|
November 14, 2024
Concerns Regarding Sample Size and Credibility of Progression-Free Survival Results-Reply
Song Dong, Hong-Hong Yan, Yi-Long Wu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2019
Reply to A. Tateishi et al
Yi-Long Wu, Wen-Zhao Zhong, Hong-Hong Yan
The Lancet. Respiratory Medicine
|
November 9, 2017
BRAIN study: it is hard to draw a conclusion - Authors' reply
Jin-Ji Yang, Hong-Hong Yan, Yi-Long Wu
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi
|
December 18, 2010
[Survey on the development regarding institution and professional contingence of injury prevention and strategy in China]
Hong-hong Yan, Xiao-mei Dong, Gui-bo Chi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 1, 2014
Efficacy of epidermal growth factor receptor inhibitors versus chemotherapy as second-line treatment in advanced non-small-cell lung cancer with wild-type EGFR: a meta-analysis of randomized controlled clinical trials
Ning Zhao, Xu-Chao Zhang, Hong-Hong Yan, et al.
International Journal of Clinical Oncology
|
October 7, 2019
Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases
Zhen Wang, Jin-Ji Yang, Hai-Yan Tu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 12, 2014
MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation
Ling Huang, She-Juan An, Zhi-Hong Chen, et al.
BMC Cancer
|
November 8, 2019
Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study
Jia-Tao Zhang, Si-Yang Liu, Hong-Hong Yan, et al.
The International Journal of Biological Markers
|
July 23, 2013
Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
Zhu Zeng, Hua-Jun Chen, Hong-Hong Yan, et al.
Nuclear Medicine Communications
|
September 22, 2011
Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?
Jin-Ji Yang, Shu-Xia Wang, Wen-Zhao Zhong, et al.
Page
of 12